The effect of medicare health care delivery systems on survival for patients with breast and colorectal cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 4, 2006, Pages 769-773

  Kirsner, Robert S ^a,b,c,e   Ma, Fangchao ^a,c   Fleming, Lora ^a   Federman, Daniel G ^d   Trapido, Edward ^a   Duncan, Robert ^a   Wilkinson, James D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; FEMALE; HEALTH CARE DELIVERY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICARE; PRIORITY JOURNAL; RACE; SOCIAL STATUS;

AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEE-FOR-SERVICE PLANS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; MEDICARE; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES;

EID: 33646258743     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0838     Document Type: Article

References (33)

1. Dutt HR. Developing Medicare HMO market areas and their implications for HMO capitation rates. Manag Care Interface 2003;16:20-5.
2. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40:3-18.
3. Federman DG, Kirsner RS. The abilities of primary care physicians in dermatology: implications for quality of care. Am J Manag Care 1997;3:1487-92.
4. Potosky AL, Merrill GM, Riley GF, et al. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients. Health Serv Res 1999;34:525-46.
5. Delaet DE, Shea S, Carrasquillo O. Receipt of preventative services among privately insured minorities in managed care versus fee-for-service insurance plans. J Gen Intern Med 2002;17:451-7.
6. Riley GF, Potosky AL, Lubitz JD, Brown ML. Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health 1994;84:1598-604.
7. Potosky AL, Breen N, Graubard BI, Parsons PE. The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med Care 1998;36:257-70.
8. Bernstein AB, Thompson GB, Harlan LC. Differences in rates of cancer screening by usual source of medical care. Data from the 1987 National Health Interview Survey. Med Care 1991;29:196-209.
9. Riley GF, Potosky AL, Klabunde CN, Warren JL, Ballard-Barbash R. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA 1999;281:720-6.
10. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
11. Sasieni PD, Adams J. Standardized lifetime risk. Am J Epidemiol 1999;149:869-75.
12. Jemel A, Murray Y, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics 2003. CA Cancer J Clin 2003;53:5-26.
13. Fentiman IS. Fixed and modifiable risk factors for breast cancer. Int J Clin Pract 2001;55:527-30.
14. Brewster A, Helzlsouer K. Breast cancer epidemiology, prevention, and early detection. Curr Opin Oncol 2001;13:420-5.
15. Mandelblatt J, Saha S, Teutsch S, et al. The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2003;139:835-42.
16. Selby JV, Friedman GD, Quesenberry CP, Jr., Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
17. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
18. [U S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams and Wilkins; 1996].
19. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
20. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
21. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of fecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
22. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with fecal-occult-blood test. Lancet 1996;348:1467-71.
23. Available at: http://seer.cancer.gov/.
24. Gornick ME, Warren JL, Eggers PW, et al. Thirty years of Medicare: impact on the covered population. Health Care Financ Rev 1996;18:179-237.
25. Potosky AL, Riley GF, Lubitz JD, et al. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993;31:732-48.
26. Kirsner RS, Ma F, Fleming L, et al. The effect of Medicare health care systems on women with breast and cervical cancer. Obstet Gynecol 2005;105:1381-8.
27. Steenland K. Henley J, Calle E, Thun M. Individual- and area-level socioeconomic status variables as predictors of mortality in a cohort of 179,383 persons. Am J Epidemiol 2004;159:1047-56.
28. Andrulis DP. Access to care is the centerpiece in the elimination of socioeconomic disparities in health. Ann Int Med 1998;129:412-6.
29. In: Collins KS, Hall A, Neuhas C, editors. US Minorities Health: A Chartbook. New York: The Commonwealth Fund; 1999.
30. Roetzheim RG, Gonzalez EC, Ferrante JM, Pal N, Van Durme DJ, Krison JP. Effects of health insurance and race outcomes on breast outcomes. Cancer 2000;89:2202-13.
31. Potosky AL, Merrill RM, Riley GF, et al. Breast cancer survival and treatment in health maintenance organizations and fee-for-service settings. J Natl Cancer Inst 1997;89:1683-91.
32. Khan MM, Tsai WC, Kung PT. Biased enrollment of Medicare beneficiaries in HMO plans - implications for Medicare costs. J Health Care Finance 2002;28:43-57.
33. Keating NL, Landrum MB, Meara E, et al. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector? J Natl Cancer Inst 2005;97:257-64.